Get started
Author

Alina Toni Küper

Observed names: A Küper, A.T. Küper, Alina Küper, Alina T Küper, Alina T. Küper, Küper, Alina, Küper, Alina Toni
ORCID: 0009-0009-4380-1629
Observed ORCID: 0009-0009-4380-1629
OpenAlex ID: A5010000796
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
2025 · Kim M Pabst, Manuel M Weber, et al. · The Lancet Oncology · 51
PDF
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors
2021 · Robert Seifert, Alina Küper, et al. · Oncology Research and Treatment · 23
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand Therapy
2024 · Alexandros Moraitis, Alina Küper, et al. · Seminars in Nuclear Medicine · 13
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
2024 · Alina T. Küper, David Kersting, et al. · Theranostics · 11
PDF
Is There a Role of Artificial Intelligence in Preclinical Imaging?
2023 · Alina Küper, Paul Blanc-Durand, et al. · Seminars in Nuclear Medicine · 10
Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AI
2025 · David Kersting, Katarzyna Borys, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 9
PDF
Thyroid Hormone Withdrawal Yields Higher 131 I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large 124 I PET/CT Dosimetry Cohort
2025 · Ieva Čiučiulkaitė, Giulia A. Zuccotti, et al. · Journal of Nuclear Medicine · 5
New targets of PET imaging for renal cancer
2025 · Y. Katayeu, V. Grünwald, et al. · Seminars in Nuclear Medicine · 4
Detection and quantification of small and low‐uptake lesions for differentiated thyroid carcinoma using non‐time‐of‐flight iodine‐124 PET/MRI
2024 · Maike E. Lindemann, Walter Jentzen, et al. · Medical Physics · 3
PDF
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [ 68 Ga]Ga-DOTATOC and [ 68 Ga]Ga-SSO120 with [ 18 F]FDG PET
2026 · Alina T. Küper, Lalith Kumar Shiyam Sundar, et al. · Journal of Nuclear Medicine · 1
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer
2026 · Alina Toni Küper, Sofia Carrilho Vaz, et al. · EJNMMI Research · 1
Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
2025 · Kim M. Pabst, Sophie C. Siegmund, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1
PDF
2597MO [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma
2025 · A.T. Küper, C. Darr, et al. · Annals of Oncology · 1
The State of the Art of Theranostics and Its Future
2026 · Caner Civan, Wolfgang P. Fendler, et al. · Journal of Nuclear Medicine
Diagnostic value of [68Ga]Ga-FAPI-46 PET in comparison to [18F]FDG PET in triple-negative breast cancer and potential for theranostic application
2026 · Alina Toni Küper, Ieva Ciuciulkaite, et al. · Scientific Reports
PDF
Einsatz Somatostatinrezeptor (SSTR)-gerichteter Radioligandentherapie (RLT) bei Patienten mit pankreatischen neuroendokrinen Tumoren (panNET) in Deutschland
2026 · M Schmidt, N Trautwein, et al. · Nuklearmedizin - NuclearMedicine
[68Ga]Ga-DPI-4452 PET/CT für das Staging von Patient:innen mit klarzelligem Nierenzellkarzinom
2026 · A Küper, D Kersting, et al. · Nuklearmedizin - NuclearMedicine
Impact of [68Ga]Ga-FAPI-46 PET/CT on Clinical Management across Multiple Tumor Entities – Results from a Prospective, Single-Center, Single-Arm Phase 2 Clinical Trial and a Prospective Registry
2026 · K Pabst, R Hamacher, et al. · Nuklearmedizin - NuclearMedicine
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer.
2026 · Küper, Alina Toni, Vaz, Sofia Carrilho, et al. · Open Access CRIS of the University of Bern
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer
2026 · Küper, Alina Toni, Vaz, Sofia Carrilho, et al. · Figshare
Additional file 1 of Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer
2026 · Küper, Alina Toni, Vaz, Sofia Carrilho, et al. · Figshare
68Ga-FAPI-46 PET/CT in der Tumordiagnostik: Ergebnisse einer prospektiven, einarmigen klinischen Interventionsstudie (NCT05160051)
2025 · K Pabst, T Bartel, et al. · Nuklearmedizin - NuclearMedicine
68 Ga-FAPI-46 PET/CT for cancer imaging: Results of a single-center, prospective, interventional, single-arm clinical trial.
2025 · Kim M. Pabst, Timo Bartel, et al. · Journal of Clinical Oncology
PDF
Clinical value of [68Ga]Ga-FAPI-46 PET in Comparison to [18F]FDG PET in Triple-negative Breast Cancer and Possible Theranostic Applications
2025 · Küper, Alina, Kersting, David, et al. · Universitätsbibliographie, Universität Duisburg-Essen
Investigation of Cardiac Amyloid Deposits as a Cause of Cardiac Dysfunction in Persons with Alzheimer's Disease : The Prospective CACAO-PET Study
2025 · Stephan, Settelmeier, Goerttler, Tsepo, et al. · Universitätsbibliographie, Universität Duisburg-Essen
Works count: 25
Citation count: 133
H-index: 6
I10-index: 5
Year
Topic
Type